Drug Shortage Report for RAN-DULOXETINE
| Report ID | 127955 |
| Drug Identification Number | 02438267 |
| Brand name | RAN-DULOXETINE |
| Common or Proper name | DULOXETINE |
| Company Name | RANBAXY PHARMACEUTICALS CANADA INC. |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | DULOXETINE |
| Strength(s) | 60MG |
| Dosage form(s) | CAPSULE (DELAYED RELEASE) |
| Route of administration | ORAL ORAL |
| Packaging size | 100 |
| ATC code | N06AX |
| ATC description | ANTIDEPRESSANTS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2020-07-01 |
| Estimated end date | 2020-12-04 |
| Actual end date | 2020-11-30 |
| Shortage status | Resolved |
| Updated date | 2020-12-03 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 126 EAST DRIVE BRAMPTON, ONTARIO CANADA L6T 1C1 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2020-12-03 | French | Compare |
| v5 | 2020-12-03 | English | Compare |
| v4 | 2020-12-03 | French | Compare |
| v3 | 2020-12-03 | English | Compare |
| v2 | 2020-11-06 | French | Compare |
| v1 | 2020-11-06 | English | Compare |
Showing 1 to 6 of 6